196 related articles for article (PubMed ID: 32448257)
21. Prevention of postpartum hemorrhage: options for home births in rural Ethiopia.
Prata N; Gessessew A; Abraha AK; Holston M; Potts M
Afr J Reprod Health; 2009 Jun; 13(2):87-95. PubMed ID: 20690252
[TBL] [Abstract][Full Text] [Related]
22. Misoprostol for prevention and treatment of postpartum hemorrhage: what do we know? What is next?
Raghavan S; Abbas D; Winikoff B
Int J Gynaecol Obstet; 2012 Oct; 119 Suppl 1():S35-8. PubMed ID: 22883912
[TBL] [Abstract][Full Text] [Related]
23. The Safety and Feasibility of a Family First Aid Approach for the Management of Postpartum Hemorrhage in Home Births: A Pre-post Intervention Study in Rural Pakistan.
Mary M; Jafarey S; Dabash R; Kamal I; Rabbani A; Abbas D; Durocher J; Tan YL; Winikoff B
Matern Child Health J; 2021 Jan; 25(1):118-126. PubMed ID: 33242210
[TBL] [Abstract][Full Text] [Related]
24. Rectally administrated misoprostol as an alternative to intravenous oxytocin infusion for preventing post-partum hemorrhage after cesarean delivery.
Chaudhuri P; Mandi S; Mazumdar A
J Obstet Gynaecol Res; 2014 Sep; 40(9):2023-30. PubMed ID: 25181622
[TBL] [Abstract][Full Text] [Related]
25. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial.
Derman RJ; Kodkany BS; Goudar SS; Geller SE; Naik VA; Bellad MB; Patted SS; Patel A; Edlavitch SA; Hartwell T; Chakraborty H; Moss N
Lancet; 2006 Oct; 368(9543):1248-53. PubMed ID: 17027730
[TBL] [Abstract][Full Text] [Related]
26. Carbetocin versus sublingual misoprostol plus oxytocin infusion for prevention of postpartum hemorrhage at cesarean section in patients with risk factors: a randomized, open trail study.
Elgafor el Sharkwy IA
Arch Gynecol Obstet; 2013 Dec; 288(6):1231-6. PubMed ID: 23689739
[TBL] [Abstract][Full Text] [Related]
27. Introduction of misoprostol for prevention of postpartum hemorrhage at the community level in Senegal.
Diadhiou M; Dieng T; Ortiz C; Mall I; Dione D; Sloan NL
Int J Gynaecol Obstet; 2011 Dec; 115(3):251-5. PubMed ID: 21982859
[TBL] [Abstract][Full Text] [Related]
28. Carbetocin versus rectal misoprostol for management of third stage of labor among women with low risk of postpartum hemorrhage.
Maged AM; Waly M; Fahmy RM; Dieb AS; Essam A; Salah NM; Hussein EA; Nabil H
Int J Gynaecol Obstet; 2020 Feb; 148(2):238-242. PubMed ID: 31736069
[TBL] [Abstract][Full Text] [Related]
29. Initiating a novel therapy in preventing postpartum hemorrhage in rural India: a joint collaboration between the United States and India.
Kodkany BS; Derman RJ; Goudar SS; Geller SE; Edlavitch SA; Naik VA; Patel A; Bellad MB; Patted SS
Int J Fertil Womens Med; 2004; 49(2):91-6. PubMed ID: 15188836
[TBL] [Abstract][Full Text] [Related]
30. Using misoprostol to treat postpartum hemorrhage in home deliveries attended by traditional birth attendants.
Abbas DF; Jehan N; Diop A; Durocher J; Byrne ME; Zuberi N; Ahmed Z; Walraven G; Winikoff B
Int J Gynaecol Obstet; 2019 Mar; 144(3):290-296. PubMed ID: 30582753
[TBL] [Abstract][Full Text] [Related]
31. Active Management of the Third Stage of Labor With a Combination of Oxytocin and Misoprostol to Prevent Postpartum Hemorrhage: A Randomized Controlled Trial.
Quibel T; Ghout I; Goffinet F; Salomon LJ; Fort J; Javoise S; Bussieres L; Aegerter P; Rozenberg P;
Obstet Gynecol; 2016 Oct; 128(4):805-11. PubMed ID: 27607864
[TBL] [Abstract][Full Text] [Related]
32. Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery.
Elbohoty AE; Mohammed WE; Sweed M; Bahaa Eldin AM; Nabhan A; Abd-El-Maeboud KH
Int J Gynaecol Obstet; 2016 Sep; 134(3):324-8. PubMed ID: 27350226
[TBL] [Abstract][Full Text] [Related]
33. The effect of prophylactic oral tranexamic acid plus buccal misoprostol on blood loss after vaginal delivery: a randomized controlled trial.
Shady NW; Sallam HF; Elsayed AH; Abdelkader AM; Ali SS; Alanwar A; Abbas AM
J Matern Fetal Neonatal Med; 2019 Jun; 32(11):1806-1812. PubMed ID: 29241383
[TBL] [Abstract][Full Text] [Related]
34. A randomized trial of sublingual misoprostol to augment routine third-stage management among women at risk of postpartum hemorrhage.
Chaudhuri P; Majumdar A
Int J Gynaecol Obstet; 2016 Feb; 132(2):191-5. PubMed ID: 26613819
[TBL] [Abstract][Full Text] [Related]
35. Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial.
Mobeen N; Durocher J; Zuberi N; Jahan N; Blum J; Wasim S; Walraven G; Hatcher J
BJOG; 2011 Feb; 118(3):353-61. PubMed ID: 21176086
[TBL] [Abstract][Full Text] [Related]
36. Postpartum hemorrhage prevention in Nepal: a program assessment.
Rajbhandari SP; Aryal K; Sheldon WR; Ban B; Upreti SR; Regmi K; Aryal S; Winikoff B
BMC Pregnancy Childbirth; 2017 Jun; 17(1):169. PubMed ID: 28583092
[TBL] [Abstract][Full Text] [Related]
37. Is attendant at delivery associated with the use of interventions to prevent postpartum hemorrhage at home births? The case of Bangladesh.
Prata N; Bell S; Holston M; Quaiyum MA
BMC Pregnancy Childbirth; 2014 Jan; 14():24. PubMed ID: 24428902
[TBL] [Abstract][Full Text] [Related]
38. Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date.
Smith JM; Gubin R; Holston MM; Fullerton J; Prata N
BMC Pregnancy Childbirth; 2013 Feb; 13():44. PubMed ID: 23421792
[TBL] [Abstract][Full Text] [Related]
39. Assessment of sublingual misoprostol as first-line treatment for primary post-partum hemorrhage: results of a multicenter trial.
Okonofua FE; Ogu RN; Akuse JT; Ujah IA; Galadanci HS; Fabamwo AO
J Obstet Gynaecol Res; 2014 Mar; 40(3):718-22. PubMed ID: 24320203
[TBL] [Abstract][Full Text] [Related]
40. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial.
Blum J; Winikoff B; Raghavan S; Dabash R; Ramadan MC; Dilbaz B; Dao B; Durocher J; Yalvac S; Diop A; Dzuba IG; Ngoc NT
Lancet; 2010 Jan; 375(9710):217-23. PubMed ID: 20060162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
